Genotype-phenotype correlations and de novo induction of cancer stem cells in Wilms tumor initiation.
N.S. Pop, Daniëlle KootiD, Conny M. BrouwersiD, Margot M. L. LinsseniD, Jill W. C. ClaassensiD, C.W.J. Cartlidge, Derya Deniz OzdemiriD, Karamjit Singh DoltiD, Peter HohensteiniD
Abstract
Wilms tumor, the most common pediatric kidney cancer, arises from abnormal embryonic kidney development. Therapy resistance and tumor recurrence remain major challenges, likely driven by the presence of Cancer Stem Cells (CSCs). Here, we elucidate the earliest pathogenic events in genetically engineered mouse models exhibiting loss of Wt1 or LIN28B overexpression, two Wilms tumor driver genes. Loss of Wt1 leads to a disturbance of lineage identity of the mutant cells, whereas LIN28B leads to a disturbed transition between uninduced and induced NPC (nephron progenitor cell) state. In both cases the appearance of cells positive for all four Wilms tumor cancer stem cell markers is the result of the tumor initiating mutation. The existence of genotype-phenotype correlations in primary developmental phenotypes and cancer stem cell expression patterns has important implications for therapeutic opportunities and requirements.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Exploiting Embryonic Niche Conditions to Grow Wilms Tumor Blastema in Culture
H. Wojcik, H. N. Lovvorn, … A. O. Perantoni·Frontiers in OncologyPeer-reviewed·Mar 16, 2023
- Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early stem cell origin
B. Royer-Pokora, W. Wruck, M. Beier·bioRxiv·Jun 10, 2022
- WILMS TUMORIGENESIS IN HUMAN KIDNEY ORGANOIDS
V. Waehle, R. Ungricht, … J. Betschinger·bioRxiv·Feb 2, 2021
- Podocyte lineage marker expression is preserved across Wilms tumor subtypes and enhanced in tumors harboring the SIX1/2 p.Q177R mutation
M. J. Stevenson, S. K. Phanor, … L. L. O'Brien·bioRxiv·Nov 2, 2022
- CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance
B. M. Foster, D. Zaidi, … B. A. Kerr·bioRxiv·Feb 11, 2018
- Mice with renal-specific alterations of stem cell-associated signaling develop symptoms of chronic kidney disease but surprisingly no tumors
A. Myszczyszyn, O. Popp, … W. Birchmeier·bioRxiv·Feb 28, 2023